← All trials
NCT06106906
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2023
- Primary completion
- Dec 31, 2024
- Completion date
- Dec 31, 2026
- First posted
- Oct 30, 2023
- Last posted
- Oct 30, 2023
- Enrollment
- 15
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Huazhong University of Science and TechnologyLead sponsor
- Guangzhou Bio-gene Technology Co., Ltd.Collaborator
- Huazhong University of Science and TechnologyReponsible party - principal investigator
- Huazhong University of Science and TechnologySponsor investigator
- Wuhan Union Hospital, ChinaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.